Jupiter Orphan Therapeutics is a clinical-stage drug platform company that specializes in treating neuroinflammation. With a mission to make a significant impact on patients and society, they have developed a safe and oral medication for Alzheimer's disease and rare diseases. Their innovative micellar technology allows them to deliver their flagship product, JOTROL™, in an easily consumable, oral softgel form without any gastrointestinal side effects.

JOTROL™ is a groundbreaking resveratrol product that has multiple potential disease applications due to its anti-inflammatory, oxidative-stress-reducing, and other mechanisms of action. Importantly, it can effectively cross the blood-brain barrier, enabling treatment of the central nervous system. Jupiter Orphan Therapeutics is actively focused on developing treatments for Alzheimer's disease and rare orphan diseases.

They are also committed to working with the best partners in their mission to provide effective treatments for these conditions. Learn more about their innovative approach and join their cause on their website